FDA Approves Fulphila
U.S. FDA Approves Fulphila (pegfilgrastim-jmdb), the First Biosimilar to Neulasta
HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India, June 4, 2018 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523,
Patients on Opioids OK With Lower Doses
FRIDAY, June 8, 2018 -- Even patients who have taken high doses of opioid painkillers for long periods of time arent unhappy with their care when their doctor lowers their dose, new research suggests.
The study
Noninvasive Blood Test Can Predict Gestational Age
FRIDAY, June 8, 2018 -- Noninvasive blood tests can predict gestational age and can identify women at risk for preterm delivery using cell-free RNA, according to a study published in the June 8 issue of
Cryoablation Efficacious for Cancer Pain, Review Finds
WEDNESDAY, May 23, 2018 -- Cryoablation is effective for controlling cancer pain without many side effects, according to a review published online May 7 in PAIN Practice.
Laura Ferrer-Mileo, from
FDA Approves Yonsa
Sun Pharma Announces FDA Approval of Yonsa (abiraterone acetate) to Treat Metastatic Castration-Resistant Prostate Cancer
MUMBAI & PRINCETON, N.J. & KING OF PRUSSIA, Pa. May 23, 2018 --(BUSINESS WIRE)--Sun Pharmaceutical Industries Lt
GSK Receives FDA Approval of Arnuity Ellipta for Asthma in Children From 5 Years of Age
London, UK 21 May 2018 --GSK today announced it has received approval from the US Food and Drug Administration (FDA) for the use of Arnuity Ellipta (fluticasone furoa